TEMELKOVA-KURKTSCHIEV, T.; HANEFELD, M. The lipid triad in type 2 diabetes –
prevalence and relevance of hypertriglyceridaemia/ low high-density lipoprotein
syndrome in type 2 diabetes. Exp Clin Endocrinol Diabetes, v.112, p.75-79, 2004.
TRIGATTI, B.; RIGOTTI, A.; KRIEGER, M. The role of high-density lipoprotein
receptor SR-B1 in cholesterol metabolism. Curr Opin Lipidol, v.11, p.123-132, 2000.
VAN DER VLIET, H.N.; SAMMELS, M.G.; LEEGWATER, A.C. J.; LEVELS, J.H.M.;
REITSMA, P.H.; BOERS, W.; CHAMULEAU, R.A.F.M. Apolipoprotein A-V. A novel
apolipoprotein associated with early phase of liver regeneration. J Biol Chem, v.
276, n. 48, p. 44512-44520, 2001.
VOGEL, F.; MOTULSKY, A.G. Human genetics: problems and approaches. 3ª ed.
Berlin: Springer-Verlag, 1997. 851 p.
VRABLÍK, M.; HORÍNEK, A.; CESKA, R.; ADÁMKOVÁ, V.; POLEDNE, R.;
HUBACEK, J.A. Ser 19→Trp polymorphism within the apolipoprotein AV gene in
hypertriglyceridaemic people. J Med Genet, v.40, p. e105, 2003.
VU-DAC, N.; GERVOIS, P.; JAKEL, H.; NOWAK, M.; BAUGÉ, E.; DEHONDT, H.;
STAELS, B.; PENNACCHIO, L.A.; RUBIN, E.M.; FRUCHART-NAJIB, J.;
FRUCHART, J-C. Apolipoprotein A5, a crucial determinant plasma triglyceride levels,
is highly responsive to peroxisome proliferator-activated receptor α activators. J Biol
Chem, v. 278. n. 20, p. 17982-17985, 2003.
WEINBERG, R.B.; COOK, V.R.; BECKSTEAD, J.A.; MARTIN, D.D.O.; GALLAGHER,
J.W.; SHELNESS, G.S.; RYAN, R.O. Structure and interfacial properties of human
apolipoprotein A-V. J Biol Chem, v.278, n.36, p.34438-34444, 2003.
WHO – World Health Organization. The World Health Report, 2004. Disponível em:
<http://www.who.int/whr/2002/en/whr2002_annex2.pdf> Acesso em: 27 jun 2004.
WILSON, P.W.; CUPPLES, L.A.; KANNEL, W.B. Is hyperglicemia associated with
cardiovascular disease? The Framingham Study. Am Heart J, v.121, p.586-590,
1991.
WRIGHT, W.T.; YOUNG, I.S.; NICHOLLS, D.P. PATTERSON, C.; LYTTLE, K.;
GRAHAM, C.A. SNPs at the APOA5 gene account for the strong association with
hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the
Northern Irish population. Atherosclerosis, v.185, p.353-360, 2005.
YOLOGLU, S.; SEZGIN, A.T.; SEZGIN, N.; OZDEMIR, R.; YESILADA, E.; TOPAL,
E. Determination of risk factors in obese and non-obese patients with coronary artery
disease. Acta Cardiol, v.60, n.6, p.625-629, 2005.
YOO, T.W.; SUNG, K.C; SHIN, H.S.; KIM, B.J.; KIM, B.S.; KANG, J.H.; LEE, M.H.;
PARK, J.R.; KIM, H.; RHEE, E.J.; LEE, W.Y.; KIM, S.W.; RYU, S.H.; KEUM, D.G.
Relashionship between serum uric acid concentration and insulin resistance and
metabolic syndrome. Circ J, v.69, p. 928-933, 2005.